纽约地区COVID-19患者急性动脉血栓栓塞的临床特征与结局
本研究回顾了2020年3月至5月期间Northwell Health系统内确诊COVID-19并发生急性动脉血栓栓塞的49例患者,发现下肢缺血最常见(71%),46%住院期间死亡,18%发生肢体丢失,提示COVID-19相关动脉血栓栓塞预后不良。
要点
- COVID-19住院患者中急性动脉血栓栓塞并不少见,下肢缺血最常见。
- 近半数患者以急性动脉缺血为首发表现,随后确诊COVID-19。
- 此类患者肢体丢失率和住院死亡率高,需积极抗栓与血管评估。
核心结论
- COVID-19患者发生急性动脉血栓栓塞与高肢体丢失率和死亡率相关,机制尚不明确。
研究设计与样本
- 回顾性队列研究,纳入2020年3月1日至5月15日Northwell Health系统内确诊COVID-19且发生急性动脉血栓栓塞的49例住院患者。
主要发现
- 中位年龄67岁(58-75),76%为男性,最常见基础疾病为高血压(53%)和糖尿病(35%)。
- 中位D-二聚体水平为2,673 ng/mL(723-7,139)。
- 血栓栓塞分布:上肢缺血7例(14%),下肢缺血35例(71%),肠缺血2例(4%),脑缺血5例(10%),6例(12%)多部位血栓。
临床怎么用
- 对COVID-19住院患者应警惕急性动脉缺血事件,尤其是下肢缺血。
- 出现急性动脉缺血时应考虑COVID-19感染可能,并评估D-二聚体等指标。
- 治疗需个体化选择抗凝、血运重建或截肢,并关注高死亡风险。
局限性
- 回顾性设计,样本量较小(49例),单中心卫生系统数据,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Coronavirus disease 2019 (COVID-19) predisposes to arterial and venous thromboembolic complications. We describe the clinical presentation, management, and outcomes of acute arterial ischemia and concomitant infection at the epicenter of cases in the United States. METHODS: Patients with confirmed COVID-19 infection between March 1, 2020 and May 15, 2020 with an acute arterial thromboembolic event were reviewed. Data collected included demographics, anatomical location of the thromboembolism, treatments, and outcomes. RESULTS: Over the 11-week period, the Northwell Health System cared for 12,630 hospitalized patients with COVID-19. A total of 49 patients with arterial thromboembolism and confirmed COVID-19 were identified. The median age was 67 years (58-75) and 37 (76%) were men. The most common preexisting conditions were hypertension (53%) and diabetes (35%). The median D-dimer level was 2,673 ng/mL (723-7,139). The distribution of thromboembolic events included upper 7 (14%) and lower 35 (71%) extremity ischemia, bowel ischemia 2 (4%), and cerebral ischemia 5 (10%). Six patients (12%) had thrombus in multiple locations. Concomitant deep vein thrombosis was found in 8 patients (16%). Twenty-two (45%) patients presented with signs of acute arterial ischemia and were subsequently diagnosed with COVID-19. The remaining 27 (55%) developed ischemia during hospitalization. Revascularization was performed in 13 (27%) patients, primary amputation in 5 (10%), administration of systemic tissue- plasminogen activator in 3 (6%), and 28 (57%) were treated with systemic anticoagulation only. The rate of limb loss was 18%. Twenty-one patients (46%) died in the hospital. Twenty-five (51%) were successfully discharged, and 3 patients are still in the hospital. CONCLUSIONS: While the mechanism of thromboembolic events in patients with COVID-19 remains unclear, the occurrence of such complication is associated with acute arterial ischemia which results in a high limb loss and mortality.
引用
- Etkin Y, Conway AM, Silpe J, et al. Acute Arterial Thromboembolism in Patients with COVID-19 in the New York City Area. Ann Vasc Surg. 2020. PMID: 32866580. doi:10.1016/j.avsg.2020.08.085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。